Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus

Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus

Alzheimer’s disease (AD) is characterized by memory loss and cognitive decline. Additionally, abnormal extracellular amyloid plaques accumulation and nerve damage caused by intracellular neurofibrillary tangles, and tau protein are characteristic of AD. Furthermore, AD is associated with oxidative s...

Full description

Bibliographic Details
Main Authors: A Young Sim, Sumit Barua, Jong Youl Kim, Yong-ho Lee, Jong Eun Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Neuroscience
Subjects:
insulin signaling
insulin resistance
Alzheimer’s disease
type 2 diabetes mellitus
DPP-4 inhibitor
SGLT2 inhibitor
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2021.708547/full

Internet

https://www.frontiersin.org/articles/10.3389/fnins.2021.708547/full

Similar Items